Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer

@article{Orouji2021ChromatinSD,
  title={Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer},
  author={Elias Orouji and Ayush T. Raman and Anand Kamal Singh and Alexey V. Sorokin and Emre Arslan and Archit K. Ghosh and Jonathan Schulz and Christopher J. Terranova and Shan Jiang and Ming Tang and Mayinuer Maitituoheti and Scot C Callahan and Praveen Barrodia and Katarzyna Tomczak and Yingda Jiang and Zhi-qin Jiang and Jennifer S. Davis and Sukhen C Ghosh and Hey Min Lee and Laura Reyes-Uribe and Kyle Chang and Yusha Liu and Huiqin Chen and Ali Azhdarinia and Jeffrey S. Morris and Eduardo Vilar and Kendra S. Carmon and Scott Kopetz and Kunal Rai},
  journal={Gut},
  year={2021},
  volume={71},
  pages={938 - 949}
}
Objective Enhancer aberrations are beginning to emerge as a key epigenetic feature of colorectal cancers (CRC), however, a comprehensive knowledge of chromatin state patterns in tumour progression, heterogeneity of these patterns and imparted therapeutic opportunities remain poorly described. Design We performed comprehensive epigenomic characterisation by mapping 222 chromatin profiles from 69 samples (33 colorectal adenocarcinomas, 4 adenomas, 21 matched normal tissues and 11 colon cancer… 

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

It is demonstrated mechanistically that PDZK1IP1 enhances the reductive capacity CRC cancer cells via the pentose phosphate pathway, and it is shown this activation enables efficient growth under oxidative conditions, challenging the previous notion thatPDZK 1IP1 acts as a tumor suppressor in CRC.

High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma

The results identify that the AT subtype of HNSCC is associated with high enhancer activity, resistance to BET inhibition, and signaling pathways that could serve as future targets for sensitizing H NSCC to BET inhibited pathways.

Computational methods to explore chromatin state dynamics

This review aims to explore the available computational tools that have been developed to capture CS alterations under two or more cellular conditions.

Endogenous retroviruses mediate transcriptional rewiring in response to oncogenic signaling in colorectal cancer

It is found that primate-specific endogenous retroviruses are an abundant source of enhancers that show cancer-specific activity and that ERV-derived enhancers mediate transcriptional dysregulation in response to oncogenic signaling, and shape the evolution of cancer- specific regulatory networks.

Refining colorectal cancer classification and clinical stratification through a single-cell atlas

A dichotomy in tumor microenvironments across CMS subgroups exists by which patients with high cancer-associated fibroblasts and C1Q+TAM content exhibit poor outcomes, providing a higher level of personalization and precision than would distinct subtypes.

DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2.

Findings reveal that the DPEP1 enhances the stemness of tumor cells by forming a positive feedback loop with ASCL2 to improve resistance to chemotherapy drugs.

References

SHOWING 1-10 OF 90 REFERENCES

Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome

The findings indicate that the CRC epigenome is defined by highly recurrent epigenetic alterations at enhancers which activate a common, aberrant transcriptional programme critical for CRC growth and survival.

Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer

Thousands of variant enhancer loci (VELs) are identified that comprise a signature that is robustly predictive of the in vivo colon cancer transcriptome that is proposed to drive a specific transcriptional program to promote colon carcinogenesis.

Mismatch repair-signature mutations activate gene enhancers across human colorectal cancer epigenomes

It is demonstrated that signature mismatch-repair (MMR) mutations activate enhancers using a xenograft tumor metastasis model, where mutations are induced naturally via CRISPR/Cas9 inactivation of MLH1 prior to tumor cell injection.

The chromatin accessibility landscape of primary human cancers

These chromatin accessibility profiles identify cancer- and tissue-specific DNA regulatory elements that enable classification of tumor subtypes with newly recognized prognostic importance, and identify distinct TF activities in cancer based on differences in the inferred patterns of TF-DNA interaction and gene expression.

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues.

Overall, this work presents a comprehensive ChIP-seq workflow that can be applied to dozens of human tumor samples and cancer cell lines to determine epigenomic aberrations in various malignancies.

Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

Dual Roles of RNF2 in Melanoma Progression.

It is established that RNF2 is prognostic, exhibiting progression-correlated expression in human melanocytic neoplasms and oncogenic and prometastatic, and the notion that epigenetic regulators, such as R NF2, directly and functionally control powerful gene networks that are vital in multiple cancer processes is supported.
...